# A Leukapheresis Study for Immune Responses in Healthy US Adults Who Receive BCG Vaccination Followed by Boosting With AERAS-402

> **NCT02375256** · PHASE1 · COMPLETED · sponsor: **Aeras** · enrollment: 11 (actual)

## Conditions studied

- Tuberculosis

## Interventions

- **BIOLOGICAL:** AERAS-402
- **BIOLOGICAL:** Placebo
- **BIOLOGICAL:** BCG (1-8 x105 cfu ID)

## Key facts

- **NCT ID:** NCT02375256
- **Lead sponsor:** Aeras
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-10
- **Primary completion:** 2010-12
- **Final completion:** 2013-12
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2015-03-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02375256

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02375256, "A Leukapheresis Study for Immune Responses in Healthy US Adults Who Receive BCG Vaccination Followed by Boosting With AERAS-402". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02375256. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*